Effects of finasteride on hematuria associated with benign prostatic hyperplasia: long-term follow-up

By Miller M.I.   Puchner P.J.  

Urology, Vol. 51, Iss. 2, 1998-02 ,pp. : 237-240

Elsevier

Access to resources Recommend Favorite

Can finasteride reverse the progress of benign prostatic hyperplasia? a two-year placebo-controlled study

By Andersen J.T.   Ekman P.   Wolf H.   Beisland H.O.   Johansson J.E.   Kontturi M.   Lehtonen T.   Tveter K.  

Urology, Vol. 46, Iss. 5, 1995-11 ,pp. : 631-637

Elsevier

Access to resources Recommend Favorite

Naftopidil and propiverine hydrochloride for treatment of male lower urinary tract symptoms suggestive of benign prostatic hyperplasia and concomitant overactive bladder: A prospective randomized controlled study

By Yokoyama Teruhiko   Uematsu Katsutoshi   Watanabe Toyohiko   Sasaki Katsumi   Kumon Hiromi   Nagai Atsushi  

Scandinavian Journal of Urology and Nephrology, Vol. 43, Iss. 4, 2009-09 ,pp. : 307-314

Informa Healthcare

Access to resources Recommend Favorite

Effects of initial combined tamsulosin and solifenacin therapy for overactive bladder and bladder outlet obstruction secondary to benign prostatic hyperplasia: a prospective, randomized, multicenter study

By Lee Seung   Byun Seok   Lee Seung   Kim Khae   Lee Ji  

International Urology and Nephrology, Vol. 46, Iss. 3, 2014-03 ,pp. : 523-529

Springer Publishing Company

Access to resources Recommend Favorite

Phase III Multicenter Placebo-Controlled Study of Tamsulosin in Benign Prostatic Hyperplasia - a randomized, controlled trial in patients with benign prostatic 'obstruction' (symptomatic BPH)

By Lepor H.  

Urology, Vol. 51, Iss. 6, 1998-06 ,pp. : 892-900

Elsevier

Access to resources Recommend Favorite